UK health minister confirms talks with AstraZeneca over new variant vaccines

imageStock Markets10 hours ago (Jun 02, 2021 16:51)

© Reuters. FILE PHOTO: Britain’s Health Secretary Matt Hancock speaks at a coronavirus media briefing at Downing Street in London, Britain May 27, 2021. Matt Dunham/Pool via REUTERS/File Photo


LONDON (Reuters) – Britain is in talks with Oxford and AstraZeneca (NASDAQ:AZN) for additional doses of their COVID-19 vaccine that has been changed to better target the “beta” coronavirus variant first identified in South Africa, health minister Matt Hancock said on Wednesday.

“We’ve started commercial negotiations with AstraZeneca to secure a variant vaccine: future supplies of the Oxford AstraZeneca vaccine that have been adapted to tackle the B.1.351 variant first identified in South Africa,” Hancock said in a speech at Oxford University.

UK health minister confirms talks with AstraZeneca over new variant vaccines

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Please enter your comment!
Please enter your name here